TSTA3 (Tissue Specific Transplantation Antigen P35B, Protein FX, GDP-L-fucose Synthase, Red Cell NADP(H)-binding Protein, Short-chain Dehydrogenase/Reductase Family 4E Member 1, GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reducta
TSTA3 (Tissue Specific Transplantation Antigen P35B, Protein FX, GDP-L-fucose Synthase, Red Cell NADP(H)-binding Protein, Short-chain Dehydrogenase/Reductase Family 4E Member 1, GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reducta
TSTA3 (Tissue Specific Transplantation Antigen P35B, Protein FX, GDP-L-fucose Synthase, Red Cell NADP(H)-binding Protein, Short-chain Dehydrogenase/Reductase Family 4E Member 1, GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reducta
Biozol Catalog Number:
USB-T9135-01-FITC
Supplier Catalog Number:
T9135-01-FITC
Alternative Catalog Number:
USB-T9135-01-FITC-100
Manufacturer:
US Biological
Host:
Mouse
Category:
Antikörper
Application:
FLISA, WB
Immunogen:
TSTA3 (NP_003304, 222-322aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26kD.
Tissue specific transplantation antigen P35B is a NADP(H)-binding protein. It catalyze the two-step epimerase and the reductase reactions in GDP-D-mannose metabolism, converting GDP-4-keto-6-D-deoxymannose to GDP-L-fucose. GDP-L-fucose is the substrate of several fucosyltransferases involved in the expression of many glycoconjugates, including blood group ABH antigens and developmental adhesion antigens. Mutations in this gene may cause leukocyte adhesion deficiency, type II. Applications: Suitable for use in FLISA and Western Blot. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: Store product at 4C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20C. Aliquots are stable at -20C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: FITC conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Note: Applications are based on unconjugated antibody.
